ProfileGDS2971 / 2.2.11.16
TitleHemiasterlin analog HTI-286 effect on docetaxel-resistant prostate cancer cell line
OrganismHomo sapiens


HTI-286 docetaxel GSM206100 GSM206166 GSM206167 GSM206168 GSM206169 GSM206170 GSM206357 GSM206358 GSM206359 GSM206360 GSM206361 GSM206362 36% 24% 8% 18% 68% 77% 65% 96% 61% 45% 67% 42% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM206100HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 1)-0.15667736
GSM206166HTI-286 in docetaxel-refractory prostate cancer (Dye Flip 1)-0.33944524
GSM206167HTI-286 in docetaxel-refractory prostate cancer Biological Replicate 2-0.8204118
GSM206168HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 3)-0.63129818
GSM206169HTI-286 in docetaxel-refractory prostate cancer (Dye flip2)0.22928868
GSM206170HTI-286 in docetaxel-refractory prostate cancer (dyeflip3)0.41396377
GSM206357HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip1)0.25054365
GSM206358HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate1)1.9752996
GSM206359HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip2)0.19090761
GSM206360HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate2)-0.028373245
GSM206361HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip3)0.30885467
GSM206362HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate3)-0.064735842